These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11567004)

  • 1. SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon.
    Nikolaus T; Deiwick J; Rappl C; Freeman JA; Schröder W; Miller SI; Hensel M
    J Bacteriol; 2001 Oct; 183(20):6036-45. PubMed ID: 11567004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC.
    Freeman JA; Rappl C; Kuhle V; Hensel M; Miller SI
    J Bacteriol; 2002 Sep; 184(18):4971-80. PubMed ID: 12193612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dissection of translocon proteins of the Salmonella pathogenicity island 2-encoded type III secretion system.
    Hölzer SU; Hensel M
    BMC Microbiol; 2010 Apr; 10():104. PubMed ID: 20377892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SsaM and SpiC interact and regulate secretion of Salmonella pathogenicity island 2 type III secretion system effectors and translocators.
    Yu XJ; Liu M; Holden DW
    Mol Microbiol; 2004 Nov; 54(3):604-19. PubMed ID: 15491354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SseA is a chaperone for the SseB and SseD translocon components of the Salmonella pathogenicity-island-2-encoded type III secretion system.
    Ruiz-Albert J; Mundy R; Yu XJ; Beuzón CR; Holden DW
    Microbiology (Reading); 2003 May; 149(Pt 5):1103-1111. PubMed ID: 12724372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of a novel surface structure encoded by Salmonella Pathogenicity Island 2.
    Chakravortty D; Rohde M; Jäger L; Deiwick J; Hensel M
    EMBO J; 2005 Jun; 24(11):2043-52. PubMed ID: 15889142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella pathogenicity island 2-encoded proteins SseC and SseD are essential for virulence and are substrates of the type III secretion system.
    Klein JR; Jones BD
    Infect Immun; 2001 Feb; 69(2):737-43. PubMed ID: 11159962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of upstream signaling events in the salmonella pathogenicity island 2 transcriptional activation pathway.
    Kim CC; Falkow S
    J Bacteriol; 2004 Jul; 186(14):4694-704. PubMed ID: 15231802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SseA acts as the chaperone for the SseB component of the Salmonella Pathogenicity Island 2 translocon.
    Zurawski DV; Stein MA
    Mol Microbiol; 2003 Mar; 47(5):1341-51. PubMed ID: 12603739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.
    Coombes BK; Lowden MJ; Bishop JL; Wickham ME; Brown NF; Duong N; Osborne S; Gal-Mor O; Finlay BB
    Infect Immun; 2007 Feb; 75(2):574-80. PubMed ID: 17158898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SpiC is required for secretion of Salmonella Pathogenicity Island 2 type III secretion system proteins.
    Yu XJ; Ruiz-Albert J; Unsworth KE; Garvis S; Liu M; Holden DW
    Cell Microbiol; 2002 Aug; 4(8):531-40. PubMed ID: 12174087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages.
    Hensel M; Shea JE; Waterman SR; Mundy R; Nikolaus T; Banks G; Vazquez-Torres A; Gleeson C; Fang FC; Holden DW
    Mol Microbiol; 1998 Oct; 30(1):163-74. PubMed ID: 9786193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional transfer of Salmonella pathogenicity island 2 to Salmonella bongori and Escherichia coli.
    Hansen-Wester I; Chakravortty D; Hensel M
    Infect Immun; 2004 May; 72(5):2879-88. PubMed ID: 15102800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems.
    Miao EA; Scherer CA; Tsolis RM; Kingsley RA; Adams LG; Bäumler AJ; Miller SI
    Mol Microbiol; 1999 Nov; 34(4):850-64. PubMed ID: 10564523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic pH is required for the functional assembly of the type III secretion system encoded by Salmonella pathogenicity island 2.
    Rappl C; Deiwick J; Hensel M
    FEMS Microbiol Lett; 2003 Sep; 226(2):363-72. PubMed ID: 14553934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SPI2-encoded SseA chaperone has discrete domains required for SseB stabilization and export, and binds within the C-terminus of SseB and SseD.
    Zurawski DV; Stein MA
    Microbiology (Reading); 2004 Jul; 150(Pt 7):2055-2068. PubMed ID: 15256549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL.
    Coombes BK; Brown NF; Valdez Y; Brumell JH; Finlay BB
    J Biol Chem; 2004 Nov; 279(48):49804-15. PubMed ID: 15383528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III secretion of Salmonella enterica serovar Typhimurium translocated effectors and SseFG.
    Hansen-Wester I; Stecher B; Hensel M
    Infect Immun; 2002 Mar; 70(3):1403-9. PubMed ID: 11854226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates.
    Chakravortty D; Hansen-Wester I; Hensel M
    J Exp Med; 2002 May; 195(9):1155-66. PubMed ID: 11994420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2.
    Husseiny MI; Wartha F; Hensel M
    Vaccine; 2007 Jan; 25(1):185-93. PubMed ID: 16887239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.